These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 24821853)
1. The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis. Malaviya AP; Ledingham J; Bloxham J; Bosworth A; Buch M; Choy E; Cope A; Isaacs J; Marshall D; Wright G; Ostör AJ; ; Rheumatology (Oxford); 2014 Jul; 53(7):1344-6. PubMed ID: 24821853 [No Abstract] [Full Text] [Related]
2. [New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)]. Nasonov EL Ter Arkh; 2010; 82(5):64-71. PubMed ID: 20597275 [TBL] [Abstract][Full Text] [Related]
4. [The importance of cytokine profile characteristics for evaluating the therapeutic effectiveness of monoclonal antibodies against IL-6 receptors in patients with rheumatoid arthritis]. Avdeev AS; Novikov AA; Aleksandrova EN; Panasiuk EIu; Nasonov EL Klin Med (Mosk); 2014; 92(1):28-34. PubMed ID: 25265656 [TBL] [Abstract][Full Text] [Related]
5. [IL-6 targeting therapy to retard structural joint damage in patients with rheumatoid arthritis]. Nishimoto N Clin Calcium; 2009 Mar; 19(3):425-31. PubMed ID: 19252253 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous tocilizumab for the treatment of rheumatoid arthritis. Mitchell E; Jones G Expert Rev Clin Immunol; 2016; 12(2):103-14. PubMed ID: 26629984 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Kivitz A; Olech E; Borofsky M; Zazueta BM; Navarro-Sarabia F; Radominski SC; Merrill JT; Rowell L; Nasmyth-Miller C; Bao M; Wright S; Pope JE Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1653-61. PubMed ID: 24942540 [TBL] [Abstract][Full Text] [Related]
8. Drug-induced hypereosinophilia related to tocilizumab therapy for rheumatoid arthritis. Morrisroe K; Wong M Rheumatology (Oxford); 2015 Nov; 54(11):2113-4. PubMed ID: 26224305 [No Abstract] [Full Text] [Related]
9. Tocilizumab for the treatment of rheumatoid arthritis. Tanaka T; Ogata A; Narazaki M Expert Rev Clin Immunol; 2010 Nov; 6(6):843-54. PubMed ID: 20979549 [TBL] [Abstract][Full Text] [Related]
11. Interlukin-6 receptor inhibitor tocilizumab: a new treatment option in rheumatoid arthritis? Johnson J; Wang MY Neurosurgery; 2008 Aug; 63(2):N8. PubMed ID: 18797345 [No Abstract] [Full Text] [Related]
12. Inhibiting interleukin-6 in rheumatoid arthritis. Choy E Curr Rheumatol Rep; 2008 Oct; 10(5):413-7. PubMed ID: 18817647 [TBL] [Abstract][Full Text] [Related]
13. Cat-scratch fever and lymphadenopathy in a rheumatoid arthritis patient on tocilizumab. Singh N; Sinclair LL; IJdo J J Clin Rheumatol; 2015 Jan; 21(1):40. PubMed ID: 25539435 [No Abstract] [Full Text] [Related]